buthionine sulfoximine has been researched along with Diabetic Nephropathies in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, ZW; Gao, CC; Jiang, X; Wang, WJ | 1 |
| Cao, M; Li, Y; Qin, Y; Wang, T; Xu, Y; Zhai, Q; Zhao, K | 1 |
| Ha, H; Jiang, Z; Kwon, MK; Lee, EA; Lee, HB; Seo, JY; Yu, MR | 1 |
| Hayward, A; Lee, A; Morocutti, A; Sethi, M; Viberti, G | 1 |
4 other study(ies) available for buthionine sulfoximine and Diabetic Nephropathies
| Article | Year |
|---|---|
Salusin‑β participates in high glucose‑induced HK‑2 cell ferroptosis in a
Topics: Buthionine Sulfoximine; Carbolines; Cell Line; Diabetic Nephropathies; Ferroptosis; Glucose; Humans; Intercellular Signaling Peptides and Proteins; Lipid Peroxidation; NF-E2-Related Factor 2; Oximes; Piperazines; Reactive Oxygen Species; Signal Transduction; Sulfonamides; Up-Regulation | 2021 |
Cyanidin-3-O-glucoside ameliorates diabetic nephropathy through regulation of glutathione pool.
Topics: Animals; Anthocyanins; Buthionine Sulfoximine; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Fibrosis; Glucose; Glucosides; Glutathione; Inflammation; Kidney; Lipid Metabolism; Male; Mice, Inbred C57BL; Obesity; Protective Agents | 2018 |
Reactive oxygen species mediate high glucose-induced plasminogen activator inhibitor-1 up-regulation in mesangial cells and in diabetic kidney.
Topics: Animals; Antioxidants; Base Sequence; Buthionine Sulfoximine; Cells, Cultured; Diabetes Mellitus, Experimental; Diabetic Nephropathies; DNA, Complementary; Fibrinolysin; Glomerular Mesangium; Glucose; Glutathione; Male; Oxidative Stress; Plasminogen Activator Inhibitor 1; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; RNA, Messenger; Taurine; Transforming Growth Factor beta; Transforming Growth Factor beta1; Up-Regulation | 2005 |
Glutathione reverses the growth abnormalities of skin fibroblasts from insulin-dependent diabetic patients with nephropathy.
Topics: Adult; Aged; Buthionine Sulfoximine; Cell Division; Cells, Cultured; Culture Media; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Dose-Response Relationship, Drug; Female; Fibroblasts; Glucose; Glutathione; Humans; Male; Middle Aged; Skin; Superoxide Dismutase | 1998 |